Tumor necrosis factor-α, interleukin-1β, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis
- 31 March 1996
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 27 (3) , 402-408
- https://doi.org/10.1016/s0272-6386(96)90364-9
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Interleukin-6 and Interleukin-8 in Dialysate and Serum From Patients on Continuous Ambulatory Peritoneal DialysisAmerican Journal of Kidney Diseases, 1993
- Reduced secretion of IL‐lβ by peritoneal cells from patients on continuous ambulatory peritoneal dialysisImmunology & Cell Biology, 1993
- Superantigens, T Cells, and MicrobesClinical Infectious Diseases, 1992
- Bacterial Toxin‐Induced Cytokine Production Studied at the Single‐Cell LevelImmunological Reviews, 1992
- Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis.Journal of Clinical Investigation, 1991
- The Proinflammatory Cytokines Interleukin-l and Tumor Necrosis Factor and Treatment of the Septic Shock SyndromeThe Journal of Infectious Diseases, 1991
- Divergent Efficacy of Antibody to Tumor Necrosis Factor- in Intravascular and Peritonitis Models of SepsisThe Journal of Infectious Diseases, 1991
- Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.The Journal of Experimental Medicine, 1989
- Human interleukin 1 beta is not secreted from hamster fibroblasts when expressed constitutively from a transfected cDNA.The Journal of cell biology, 1988
- Occurrence of P-fimbriatedEscherichia coli in patients with bacteremiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1985